EJCTS Click here to go to Edwards website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Edvin Prifti
Massimo Bonacchi
Fabio Miraldi
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prifti, E.
Right arrow Articles by Miraldi, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prifti, E.
Right arrow Articles by Miraldi, F.

Eur J Cardiothorac Surg 2000;17:760-762
© 2000 Elsevier Science NL


Case report

Undergoing cardiopulmonary bypass using enoxaparin only during a cardiac transplantation procedure

Edvin Priftia, Massimo Bonacchia, Marzia Leaccheb, Fabio Miraldia

a Istituto di Chirurgia Toracica, Cardiovascolare e Technologie Biomediche, Università degli Studi di Siena, Siena, Italy
b Istituto di Chirurgia del Cuore e dei Grossi Vasi, Università degli Studi di Roma, "La Sapienza", Rome, Italy

Corresponding author. Istituto di Chirurgia del Cuore e dei Grossi Vasi, Policlinico Umberto I, Universita degli Studi di Roma ‘La Sapienza’, Viale del Policlinico, 155, 00161, Rome, Italy. Tel.: +-39-6-499-72693; fax: +39-6-499-72410
e-mail: edvinprifti{at}hotmail.com

The use of enoxaparin as a replacement drug to standard heparin, for anticoagulation during extracorporeal circulation, in patients with heparin-induced thrombocytopenia, is still very limited. Enoxaparin significantly reduces thrombin formation and activity during cardiopulmonary bypass. The prolonged circulating rate, slow elimination rate and non-total reversion of enoxaparin by protamine can induce important postoperative bleeding. We are describing the first case of cardiac transplantation where enoxaparin was used as a replacement drug to standard heparin.

Key Words: Enoxaparin • Cardiac transplantation • Heparin-induced thrombocytopenia




This article has been cited by other articles:


Home page
ICVTSHome page
L. Mildh, P. Tynkkynen, I. Mattila, and P. Rautiainen
Initial experience of enoxaparine as anticoagulant during mechanical circulatory support in children
Interactive CardioVascular and Thoracic Surgery, August 1, 2006; 5(4): 499 - 501.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
W. J DeBois, J. Liu, L. Y Lee, L. N Girardi, C. Mack, A. Tortolani, K. H Krieger, and O W. Isom
Diagnosis and treatment of heparin-induced thrombocytopenia
Perfusion, January 1, 2003; 18(1): 47 - 53.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. K.S. Nair, L. S. Zisman, E. Lader, A. Dimova, and C. C. Canver
Heart transplant for anomalous origin of left coronary artery from pulmonary artery
Ann. Thorac. Surg., January 1, 2003; 75(1): 282 - 284.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.